Samer Ezziddin

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 54

Top Topics

Benign Prostatic Hyperplasia

Positron Emission Tomography

Top Venues

Diagnostics (Basel, Switzerland)

European journal of nuclear medicine and molecular imaging

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Suginthan Markandu, Arne Blickle, Caroline Alexandra Burgard, Marc Remke, Katrin Altmeyer, Mathias Wagner, Samer Ezziddin, Florian Rosar
Mind the Pitfall: Solitary Nodular Fasciitis Mimicking Extra-Nodal Manifestation of Hodgkin Lymphoma on [ 18 F]FDG PET/CT. Diagnostics (Basel, Switzerland) 14 (8) (2024)
Florian Rosar, Caroline Burgard, Elena Larsen, Fadi Khreish, Robert J Marlowe, Andrea Schaefer-Schuler, Stephan Maus, Sven Petto, Mark Bartholomä, Samer Ezziddin
[ 89 Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [ 68 Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis. Cancer imaging : the official publication of the International Cancer Imaging Society 24 (1) (2024)
Florian Rosar, Caroline Burgard, Luna Vanessa Rohloff, Arne Blickle, Mark Bartholomä, Stephan Maus, Sven Petto, Andrea Schaefer-Schuler, Samer Ezziddin
225Ac-PSMA-617 Augmentation in High-Risk mCRPC Undergoing 177Lu-PSMA-617 Radioligand Therapy: Pilot Experience From a Prospective Registry. Clinical nuclear medicine (2024)
Florian Rosar, Caroline Burgard, Scott David, Robert J Marlowe, Mark Bartholomä, Stephan Maus, Sven Petto, Fadi Khreish, Andrea Schaefer-Schuler, Samer Ezziddin
Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT. Scientific reports 14 (1) (2024)
Florian Rosar, Caroline Burgard, Luna Vanessa Rohloff, Arne Blickle, Mark Bartholomä, Stephan Maus, Sven Petto, Andrea Schaefer-Schuler, Samer Ezziddin
225 Ac-PSMA-617 Augmentation in High-Risk mCRPC Undergoing 177 Lu-PSMA-617 Radioligand Therapy : Pilot Experience From a Prospective Registry. Clinical nuclear medicine 49 (7) (2024)
Florian Rosar, Caroline Burgard, Scott David, Robert J Marlowe, Mark Bartholomä, Stephan Maus, Sven Petto, Fadi Khreish, Andrea Schaefer-Schuler, Samer Ezziddin
Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT. Scientific reports 14 (1) (2024)
Alexander Bellendorf, Nicolai Mader, Stefan P Mueller, Samer Ezziddin, Andreas Bockisch, Hong Grafe, Jan Best, Juliane Goebel, Thorsten D Pöppel, Amir Sabet
Safety and Efficacy of Selective Internal Radionuclide Therapy with 90 Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Alexander Bellendorf, Nicolai Mader, Stefan P Mueller, Samer Ezziddin, Andreas Bockisch, Hong Grafe, Jan Best, Juliane Goebel, Thorsten D Pöppel, Amir Sabet
Safety and Efficacy of Selective Internal Radionuclide Therapy with 90 Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Florian Rosar, Caroline Burgard, Elena Larsen, Fadi Khreish, Robert J Marlowe, Andrea Schaefer-Schuler, Stephan Maus, Sven Petto, Mark Bartholomä, Samer Ezziddin
[ 89 Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [ 68 Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis. Cancer imaging : the official publication of the International Cancer Imaging Society 24 (1) (2024)
Moritz B Bastian, Arne Blickle, Caroline Alexandra Burgard, Octavian Fleser, Konstantinos Christofyllakis, Samer Ezziddin, Florian Rosar
Histopathological Confirmed Polycythemia Vera with Transformation to Myelofibrosis Depicted on [ 18 F]FDG PET/CT. Diagnostics (Basel, Switzerland) 14 (10) (2024)
Connor Hein, Caroline Alexandra Burgard, Arne Blickle, Moritz B Bastian, Stephan Maus, Andrea Schaefer-Schuler, Manuela Andrea Hoffmann, Mathias Schreckenberger, Samer Ezziddin, Florian Rosar
Analysis of Molecular Imaging and Laboratory Baseline Biomarkers in PSMA-RLT: Whole-Body Total Lesion PSMA (TLP) Predicts Overall Survival. Cancers 16 (15) (2024)
Florian Rosar, Caroline Burgard, Elena Larsen, Fadi Khreish, Robert J Marlowe, Andrea Schaefer-Schuler, Stephan Maus, Sven Petto, Mark Bartholomä, Samer Ezziddin
[ 89 Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [ 68 Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis. Cancer imaging : the official publication of the International Cancer Imaging Society 24 (1) (2024)
Florian Rosar, Joelle Schuler, Caroline Burgard, Arne Blickle, Mark Bartholomä, Stephan Maus, Sven Petto, Fadi Khreish, Andrea Schaefer, Samer Ezziddin
Efficacy and safety of rechallenge [ 177 Lu]Lu-PSMA-617 RLT after initial partial remission in patients with mCRPC: evaluation of a prospective registry (REALITY study). European journal of nuclear medicine and molecular imaging (2024)
Suginthan Markandu, Arne Blickle, Caroline Alexandra Burgard, Marc Remke, Katrin Altmeyer, Mathias Wagner, Samer Ezziddin, Florian Rosar
Mind the Pitfall: Solitary Nodular Fasciitis Mimicking Extra-Nodal Manifestation of Hodgkin Lymphoma on [ 18 F]FDG PET/CT. Diagnostics (Basel, Switzerland) 14 (8) (2024)
Alexander Bellendorf, Nicolai Mader, Stefan P Mueller, Samer Ezziddin, Andreas Bockisch, Hong Grafe, Jan Best, Juliane Goebel, Thorsten D Pöppel, Amir Sabet
Safety and Efficacy of Selective Internal Radionuclide Therapy with 90 Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Suginthan Markandu, Arne Blickle, Caroline Alexandra Burgard, Marc Remke, Katrin Altmeyer, Mathias Wagner, Samer Ezziddin, Florian Rosar
Mind the Pitfall: Solitary Nodular Fasciitis Mimicking Extra-Nodal Manifestation of Hodgkin Lymphoma on [ 18 F]FDG PET/CT. Diagnostics (Basel, Switzerland) 14 (8) (2024)
Florian Rosar, Caroline Burgard, Scott David, Robert J Marlowe, Mark Bartholomä, Stephan Maus, Sven Petto, Fadi Khreish, Andrea Schaefer-Schuler, Samer Ezziddin
Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT. Scientific reports 14 (1) (2024)
Florian Rosar, Caroline Burgard, Luna Vanessa Rohloff, Arne Blickle, Mark Bartholomä, Stephan Maus, Sven Petto, Andrea Schaefer-Schuler, Samer Ezziddin
225 Ac-PSMA-617 Augmentation in High-Risk mCRPC Undergoing 177 Lu-PSMA-617 Radioligand Therapy : Pilot Experience From a Prospective Registry. Clinical nuclear medicine 49 (7) (2024)
Florian Rosar, Joelle Schuler, Caroline Burgard, Arne Blickle, Mark Bartholomä, Stephan Maus, Sven Petto, Fadi Khreish, Andrea Schaefer, Samer Ezziddin
Efficacy and safety of rechallenge [ 177 Lu]Lu-PSMA-617 RLT after initial partial remission in patients with mCRPC: evaluation of a prospective registry (REALITY study). European journal of nuclear medicine and molecular imaging (2024)
Connor Hein, Caroline Alexandra Burgard, Arne Blickle, Moritz B Bastian, Stephan Maus, Andrea Schaefer-Schuler, Manuela Andrea Hoffmann, Mathias Schreckenberger, Samer Ezziddin, Florian Rosar
Analysis of Molecular Imaging and Laboratory Baseline Biomarkers in PSMA-RLT: Whole-Body Total Lesion PSMA (TLP) Predicts Overall Survival. Cancers 16 (15) (2024)
Florian Rosar, Caroline Burgard, Elena Larsen, Fadi Khreish, Robert J Marlowe, Andrea Schaefer-Schuler, Stephan Maus, Sven Petto, Mark Bartholomä, Samer Ezziddin
[ 89 Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [ 68 Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis. Cancer imaging : the official publication of the International Cancer Imaging Society 24 (1) (2024)
Florian Rosar, Caroline Burgard, Scott David, Robert J Marlowe, Mark Bartholomä, Stephan Maus, Sven Petto, Fadi Khreish, Andrea Schaefer-Schuler, Samer Ezziddin
Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT. Scientific reports 14 (1) (2024)
Moritz B Bastian, Arne Blickle, Caroline Alexandra Burgard, Octavian Fleser, Konstantinos Christofyllakis, Samer Ezziddin, Florian Rosar
Histopathological Confirmed Polycythemia Vera with Transformation to Myelofibrosis Depicted on [ 18 F]FDG PET/CT. Diagnostics (Basel, Switzerland) 14 (10) (2024)
Florian Rosar, Joelle Schuler, Caroline Burgard, Arne Blickle, Mark Bartholomä, Stephan Maus, Sven Petto, Fadi Khreish, Andrea Schaefer, Samer Ezziddin
Efficacy and safety of rechallenge [ 177 Lu]Lu-PSMA-617 RLT after initial partial remission in patients with mCRPC: evaluation of a prospective registry (REALITY study). European journal of nuclear medicine and molecular imaging (2024)
Caroline Alexandra Burgard, Manuela Andrea Hoffmann, Madita Frei, Hans-Georg Buchholz, Fadi Khreish, Robert J Marlowe, Mathias Schreckenberger, Samer Ezziddin, Florian Rosar
Detection Efficacy of 68 Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center "Real-World" Experience. Cancers 15 (5) (2023)
Caroline Alexandra Burgard, Florian Rosar, Robert J Marlowe, Mark D Bartholomä, Sebastian Dewes, Andrea Schaefer-Schuler, Johannes Linxweiler, Fadi Khreish, Samer Ezziddin
Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations. Cancers 15 (9) (2023)
Caroline Alexandra Burgard, Florian Rosar, Robert J Marlowe, Mark D Bartholomä, Sebastian Dewes, Andrea Schaefer-Schuler, Johannes Linxweiler, Fadi Khreish, Samer Ezziddin
Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations. Cancers 15 (9) (2023)
Florian Rosar, Fadi Khreish, Robert J Marlowe, Andrea Schaefer-Schuler, Caroline Burgard, Stephan Maus, Sven Petto, Mark Bartholomä, Samer Ezziddin
Detection efficacy of [ 89 Zr]Zr-PSMA-617 PET/CT in [ 68 Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer. European journal of nuclear medicine and molecular imaging (2023)
Florian Rosar, Caroline Alexandra Burgard, Raffaele Gargiulo, Samer Ezziddin
Active Lumbar Spondylodiscitis on [ 68 Ga]Ga-PSMA-11 PET/CT Mimicking Bone Metastasis. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Florian Rosar, Caroline Alexandra Burgard, Johannes Linxweiler, Mathias Wagner, Samer Ezziddin
Histologically Confirmed Testicular Metastasis Revealed by [ 89 Zr]Zr-PSMA-617 PET/CT in a Patient with Biochemical Recurrence of Prostate Cancer and Negative Conventional PSMA PET/CT Imaging. Diagnostics (Basel, Switzerland) 13 (7) (2023)
Caroline Alexandra Burgard, Manuela Andrea Hoffmann, Madita Frei, Hans-Georg Buchholz, Fadi Khreish, Robert J Marlowe, Mathias Schreckenberger, Samer Ezziddin, Florian Rosar
Detection Efficacy of 68 Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center "Real-World" Experience. Cancers 15 (5) (2023)
Florian Rosar, Caroline Alexandra Burgard, Raffaele Gargiulo, Samer Ezziddin
Active Lumbar Spondylodiscitis on [ 68 Ga]Ga-PSMA-11 PET/CT Mimicking Bone Metastasis. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Florian Rosar, Caroline Alexandra Burgard, Raffaele Gargiulo, Samer Ezziddin
Active Lumbar Spondylodiscitis on [ 68 Ga]Ga-PSMA-11 PET/CT Mimicking Bone Metastasis. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Florian Rosar, Hanna Bader, Mark D Bartholomä, Stephan Maus, Caroline Alexandra Burgard, Johannes Linxweiler, Fadi Khreish, Samer Ezziddin
Addition of Standard Enzalutamide Medication Shows Synergistic Effects on Response to [ 177 Lu]Lu-PSMA-617 Radioligand Therapy in mCRPC Patients with Imminent Treatment Failure-Preliminary Evidence of Pilot Experience. Cancers 14 (11) (2022)
Amina Banda, Bastiaan M Privé, Youssra Allach, Maike J M Uijen, Steffie M B Peters, Cato C Loeff, Martin Gotthardt, Constantijn H J Muselaers, J Alfred Witjes, Inge M van Oort, J P Michiel Sedelaar, Harm Westdorp, Niven Mehra, Fadi Khreish, Samer Ezziddin, Amir Sabet, Michael Christoph Kreissl, Thomas Winkens, Philipp Seifert, Marcel J R Janssen, Willemijn A M van Gemert, James Nagarajah
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study. Cancers 15 (1) (2022)
Florian Rosar, Andrea Schaefer-Schuler, Mark Bartholomä, Stephan Maus, Sven Petto, Caroline Burgard, Bastiaan M Privé, Gerben M Franssen, Yvonne H W Derks, James Nagarajah, Fadi Khreish, Samer Ezziddin
[<sup>89</sup>Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates. European journal of nuclear medicine and molecular imaging 49 (13) (2022)
Amina Banda, Bastiaan M Privé, Youssra Allach, Maike J M Uijen, Steffie M B Peters, Cato C Loeff, Martin Gotthardt, Constantijn H J Muselaers, J Alfred Witjes, Inge M van Oort, J P Michiel Sedelaar, Harm Westdorp, Niven Mehra, Fadi Khreish, Samer Ezziddin, Amir Sabet, Michael Christoph Kreissl, Thomas Winkens, Philipp Seifert, Marcel J R Janssen, Willemijn A M van Gemert, James Nagarajah
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study. Cancers 15 (1) (2022)
Florian Rosar, Robert Neher, Caroline Alexandra Burgard, Johannes Linxweiler, Mathias Schreckenberger, Manuela Andrea Hoffmann, Mark D Bartholomä, Fadi Khreish, Samer Ezziddin
Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPC. Cancers 14 (7) (2022)
Florian Rosar, Caroline Alexandra Burgard, Jan Philipp Kühn, Phillip R Stahl, Fadi Khreish, Samer Ezziddin
Strongly Radioiodine-Positive Pancreatic Adenocarcinoma Mimicking Metastasis of Differentiated Thyroid Cancer. Diagnostics (Basel, Switzerland) 12 (8) (2022)
Caroline Alexandra Burgard, Florian Rosar, Fadi Khreish, Samer Ezziddin
Systemic Mastocytosis Treatment with Midostaurin: [ 18 F]FDG PET/CT as a Potential Monitoring Tool for Therapy Outcome. Diagnostics (Basel, Switzerland) 12 (3) (2022)
Florian Rosar, Caroline Alexandra Burgard, Christian Neubert, Phillip R Stahl, Fadi Khreish, Samer Ezziddin
PSMA-Positive Follicular Thyroid Carcinoma Incidentally Detected by [ 68 Ga]Ga-PSMA-11 PET/CT: Correlation with Immunohistology Confirms Neovascular PSMA-Expression. Diagnostics (Basel, Switzerland) 12 (5) (2022)
Amina Banda, Bastiaan M Privé, Youssra Allach, Maike J M Uijen, Steffie M B Peters, Cato C Loeff, Martin Gotthardt, Constantijn H J Muselaers, J Alfred Witjes, Inge M van Oort, J P Michiel Sedelaar, Harm Westdorp, Niven Mehra, Fadi Khreish, Samer Ezziddin, Amir Sabet, Michael Christoph Kreissl, Thomas Winkens, Philipp Seifert, Marcel J R Janssen, Willemijn A M van Gemert, James Nagarajah
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study. Cancers 15 (1) (2022)
Florian Rosar, Felix Wenner, Fadi Khreish, Sebastian Dewes, Gudrun Wagenpfeil, Manuela A Hoffmann, Mathias Schreckenberger, Mark Bartholomä, Samer Ezziddin
Early molecular imaging response assessment based on determination of total viable tumor burden in [68Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [177Lu]Lu-PSMA-617 radioligand therapy. European journal of nuclear medicine and molecular imaging (2021)
Fadi Khreish, Mona Wiessner, Florian Rosar, Zaidoon Ghazal, Amir Sabet, Stephan Maus, Johannes Linxweiler, Mark D Bartholomä, Samer Ezziddin
Response Assessment and Prediction of Progression-Free Survival by 68Ga-PSMA-11 PET/CT Based on Tumor-to-Liver Ratio (TLR) in Patients with mCRPC Undergoing 177Lu-PSMA-617 Radioligand Therapy. Biomolecules 11 (8) (2021)
Bastiaan M Privé, Peter H J Slootbeek, Babette I Laarhuis, Samhita Pamidimarri Naga, Maarten J van der Doelen, Ludwike W M van Kalmthout, Bart de Keizer, Samer Ezziddin, Clemens Kratochwil, Alfred Morgenstern, Frank Bruchertseifer, Marjolijn J L Ligtenberg, J Alfred Witjes, Inge M van Oort, Martin Gotthardt, Sandra Heskamp, Marcel J R Janssen, Maarten J van der Doelen, James Nagarajah, Niven Mehra
Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2021)
Amir Sabet, Nicolai Mader, Jörg Thomas Bittenbring, Fadi Khreish, Frank Grünwald, Hans Jürgen Biersack, Samer Ezziddin
Prophylactic Peripheral Blood Stem Cell Collection in Patients with Extensive Bone-Marrow Infiltration of Neuroendocrine Tumours Prior to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Fadi Khreish, Zaidoon Ghazal, Robert J Marlowe, Florian Rosar, Amir Sabet, Stephan Maus, Johannes Linxweiler, Mark Bartholomä, Samer Ezziddin
177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study). European journal of nuclear medicine and molecular imaging (2021)
Florian Rosar, Niklas Kochems, Mark Bartholomä, Stephan Maus, Tobias Stemler, Johannes Linxweiler, Fadi Khreish, Samer Ezziddin
Renal Safety of [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function. Cancers 13 (12) (2021)
Fadi Khreish, Kalle Ribbat, Mark D Bartholomä, Stephan Maus, Tobias Stemler, Ina Hierlmeier, Johannes Linxweiler, Mathias Schreckenberger, Samer Ezziddin, Florian Rosar
Value of Combined PET Imaging with [18F]FDG and [68Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [177Lu]Lu-PSMA-617 RLT. Cancers 13 (16) (2021)
Alton O Sartor, Christian Peter la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Elllinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen, Daniel Y Song
Lutetium-177-prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2021)
Florian Rosar, Sebastian Dewes, Martin Ries, Andrea Schaefer, Fadi Khreish, Stephan Maus, Hendrik Bohnenberger, Johannes Linxweiler, Mark Bartholomä, Carsten Ohlmann, Samer Ezziddin
New insights in the paradigm of upregulation of tumoral PSMA expression by androgen receptor blockade: Enzalutamide induces PSMA upregulation in castration-resistant prostate cancer even in patients having previously progressed on enzalutamide. European journal of nuclear medicine and molecular imaging 47 (3) (2020)
Fadi Khreish, Florian Rosar, Clemens Kratochwil, Frederik Lars Giesel, Uwe Haberkorn, Samer Ezziddin
Positive FAPI-PET/CT in a metastatic castration-resistant prostate cancer patient with PSMA-negative/FDG-positive disease. European journal of nuclear medicine and molecular imaging 47 (8) (2019)
Fadi Khreish, Niklas Ebert, Martin Ries, Stephan Maus, Florian Rosar, Hendrik Bohnenberger, Tobias Stemler, Matthias Saar, Mark Bartholomä, Samer Ezziddin
225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience. European journal of nuclear medicine and molecular imaging 47 (3) (2019)
Amir Sabet, Ina Binse, Semih Dogan, Andrea Koch, Sandra J Rosenbaum-Krumme, Hans-Jürgen Biersack, Kim Biermann, Samer Ezziddin
Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma. European journal of nuclear medicine and molecular imaging 44 (2) (2016)